.alpha.-Substituted ketonitrone derivatives
    1.
    发明授权
    .alpha.-Substituted ketonitrone derivatives 失效
    α-取代的酮酮衍生物

    公开(公告)号:US4871862A

    公开(公告)日:1989-10-03

    申请号:US254548

    申请日:1988-10-06

    IPC分类号: C07D249/08 C07D521/00

    摘要: .alpha.-Substituted ketonitrone derivatives containing substituents selected from hydrogen, phenyl, substituted phenyl, naphthyl, furan, thiophen, imidazolylmethyl and triazolylmethyl are useful as intermediates for the preparation of biologically active isoxazolidine compounds.

    摘要翻译: 含有选自氢,苯基,取代的苯基,萘基,呋喃,噻吩,咪唑基甲基和三唑基甲基的取代基的α-取代的酮腈衍生物可用作制备生物活性异恶唑烷化合物的中间体。

    Adamantyl phenyl .beta.-alanines
    3.
    发明授权
    Adamantyl phenyl .beta.-alanines 失效
    金刚烷基苯基β-丙氨酸

    公开(公告)号:US4691051A

    公开(公告)日:1987-09-01

    申请号:US870553

    申请日:1986-06-04

    IPC分类号: C07D205/12 C07C101/08

    CPC分类号: C07D205/12

    摘要: Adamantyl phenyl .beta.-alanines having the structure: ##STR1## wherein R is phenyl or substituted phenyl and one of R.sup.1 and R.sup.2 is NH.sub.2 and the other is CO.sub.2 H, are disclosed herein.

    摘要翻译: 具有以下结构的金刚烷基苯基β-丙氨酸:其中R是苯基或取代的苯基,R 1和R 2之一是NH 2,另一个是CO 2 H。

    Adamantyl containing 1,4-oxazinone derivatives
    7.
    发明授权
    Adamantyl containing 1,4-oxazinone derivatives 失效
    含有1,4-恶嗪酮衍生物的金刚烷基

    公开(公告)号:US4549014A

    公开(公告)日:1985-10-22

    申请号:US647787

    申请日:1984-09-06

    IPC分类号: C07D265/32 C07D265/34

    CPC分类号: C07D265/32 C07D265/34

    摘要: Antimicrobial or anti-inflammatory 1,4-oxazinone derivatives of the structure: ##STR1## wherein one of R and R.sup.1 is hydrogen and the other is --CH.sub.2 CO.sub.2 R.sup.6 (R.sup.6 =alkyl) or R and R.sup.1 together represent the group .dbd.CHCO.sub.2 R.sup.6, R.sup.2 and R.sup.3 are hydrogen, alkyl, substituted alkyl, phenyl or substituted phenyl or R.sup.2 and R.sup.3 together represent a single adamantyl group, and R.sup.4 and R.sup.5 are hydrogen, alkyl, substituted alkyl, phenyl, substituted phenyl, or benzyl, are disclosed herein.

    摘要翻译: 下列结构的抗微生物或抗炎的1,4-恶嗪酮衍生物:其中R和R 1之一是氢,另一个是-CH 2 CO 2 R 6(R 6 =烷基)或R和R 1一起代表基团= CHCO 2 R 6,R 2和 R3是氢,烷基,取代的烷基,苯基或取代的苯基,或者R 2和R 3一起代表单一的金刚烷基,R4和R5是氢,烷基,取代的烷基,苯基,取代的苯基或苄基。

    3,5-diphenyl-3-[(1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl)]-
2
    8.
    发明授权
    3,5-diphenyl-3-[(1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl)]- 2 失效
    3,5-二苯基-3 - [(1H-咪唑-1-基甲基)或(1H-1,2,4-三唑-1-基甲基)] - 2-甲基-4-异恶唑啉

    公开(公告)号:US4835283A

    公开(公告)日:1989-05-30

    申请号:US167673

    申请日:1988-03-07

    IPC分类号: C07D413/06

    CPC分类号: C07D413/06

    摘要: This invention pertains generally to substituted 2-methylisoxazolines and more specifically to 3,5-diphenyl-3-[(1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-yl-methyl)]-2-methyl-4-isoxazoline derivatives which are useful as antifungal agents.

    摘要翻译: 本发明一般涉及取代的2-甲基异恶唑啉,更具体地涉及3,5-二苯基-3 - [(1H-咪唑-1-基甲基)或(1H-1,2,4-三唑-1-基 - 甲基)] -2-甲基-4-异恶唑啉衍生物,其可用作抗真菌剂。